Your browser doesn't support javascript.
loading
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
Christopherson, Pamela A; Haberichter, Sandra L; Flood, Veronica H; Perry, Crystal L; Sadler, Brooke E; Bellissimo, Daniel B; Di Paola, Jorge; Montgomery, Robert R.
Affiliation
  • Christopherson PA; Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
  • Haberichter SL; Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
  • Flood VH; Division of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Perry CL; Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.
  • Sadler BE; Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
  • Bellissimo DB; Division of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Di Paola J; Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.
  • Montgomery RR; Versiti Blood Research Institute, Milwaukee, Wisconsin, USA.
J Thromb Haemost ; 20(7): 1576-1588, 2022 07.
Article in En | MEDLINE | ID: mdl-35343054
BACKGROUND: Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF). OBJECTIVES: As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and severity, and determine the inheritance pattern found in type 3 VWD families. PATIENTS/METHODS: 62 index cases with a pre-existing diagnosis of type 3 VWD were analyzed. Central testing included FVIII, VWF:Ag, VWF:RCo, and VWFpp. Bleeding symptoms were quantified using the ISTH bleeding score. Genetic analysis included VWF sequencing, comparative genomic hybridization and predictive computational programs. RESULTS: 75% of subjects (46) had central testing confirming type 3, while 25% were re-classified as type 1-Severe or type 1C. Candidate VWF variants were found in all subjects with 93% of expected alleles identified. The majority were null alleles including frameshift, nonsense, splice site, and large deletions, while 13% were missense variants. Additional studies on 119 family members, including 69 obligate carriers, revealed a wide range of heterogeneity in VWF levels and bleeding scores, even amongst those with the same variant. Co-dominant inheritance was present in 51% of families and recessive in 21%, however 28% were ambiguous. CONCLUSION: This report represents a large cohort of VWD families in the U.S. with extensive phenotypic and genotypic data. While co-dominant inheritance was seen in approximately 50% of families, this study highlights the complexity of VWF genetics due to the heterogeneity found in both VWF levels and bleeding tendencies amongst families with type 3 VWD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Von Willebrand Disease, Type 3 Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Von Willebrand Disease, Type 3 Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom